Axsome Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Axsome Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2023 to Q3 2024.
  • Axsome Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -90.5 %.
  • Axsome Therapeutics, Inc. annual Operating Margin for 2023 was -85.7 %, a 76.2% increase from 2022.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -90.5 Jul 1, 2024 Sep 30, 2024
Q2 2024 -105 Apr 1, 2024 Jun 30, 2024
Q1 2024 -117 Jan 1, 2024 Mar 31, 2024
Q4 2023 -85.7 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.